Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Raisler

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|January 15, 2008
Toward a higher fidelity model of AMDBrian J Raisler, Miho Nozaki, Judit Baffi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2002
Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularizationBrian J Raisler, Kenneth I Berns, Maria B Grant, et al.
The Journal of Clinical Investigation|February 3, 2006
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-AMiho Nozaki, Eiji Sakurai, Brian J Raisler, et al.
Investigative Ophthalmology & Visual Science|May 31, 2002
AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularizationKeisuke Mori, Peter Gehlbach, Satoru Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2006
Drusen complement components C3a and C5a promote choroidal neovascularizationMiho Nozaki, Brian J Raisler, Eiji Sakurai, et al.
Nature|June 16, 2009
CCR3 is a target for age-related macular degeneration diagnosis and therapyAtsunobu Takeda, Judit Z Baffi, Mark E Kleinman, et al.
Nature|October 20, 2006
Corneal avascularity is due to soluble VEGF receptor-1Balamurali K Ambati, Miho Nozaki, Nirbhai Singh, et al.
Molecular Vision|June 1, 2006
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California)Gerard A Lutty, Tailoi Chan-Ling, Dale L Phelps, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|January 15, 2008
Toward a higher fidelity model of AMDBrian J Raisler, Miho Nozaki, Judit Baffi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2002
Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularizationBrian J Raisler, Kenneth I Berns, Maria B Grant, et al.
The Journal of Clinical Investigation|February 3, 2006
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-AMiho Nozaki, Eiji Sakurai, Brian J Raisler, et al.
Investigative Ophthalmology & Visual Science|May 31, 2002
AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularizationKeisuke Mori, Peter Gehlbach, Satoru Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2006
Drusen complement components C3a and C5a promote choroidal neovascularizationMiho Nozaki, Brian J Raisler, Eiji Sakurai, et al.
Nature|June 16, 2009
CCR3 is a target for age-related macular degeneration diagnosis and therapyAtsunobu Takeda, Judit Z Baffi, Mark E Kleinman, et al.
Nature|October 20, 2006
Corneal avascularity is due to soluble VEGF receptor-1Balamurali K Ambati, Miho Nozaki, Nirbhai Singh, et al.
Molecular Vision|June 1, 2006
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California)Gerard A Lutty, Tailoi Chan-Ling, Dale L Phelps, et al.
Pageof 1